Tiamat Sciences

Tiamat is a start-up producing affordable animal-free growth factors and biomolecules using plants as bioreactors. Thanks to its propriety platform, the company can manufacture a wide range of high-value proteins from antigens to growth factors.

The company has already achieved a 10x cost reduction and at scale can get costs down 1000x even at 80% growth-margins, giving them a wide ability to price strategically. the coming years. The low investment needed to build a facility (up to 40x less than current solutions) combined with its unique technology makes Tiamat the ideal partner in production scale-up for promising markets that will soon become enormous such as cellular agriculture or cell & gene therapy.

Tiamat Sciences headquartered in United States, North America, operates in the Biotechnology, Food and Beverage, AgTech, Medical sector. The company focuses on Biotechnology and has secured $531.4M in funding across 96 round(s). With a team of 1-10 employees, Tiamat Sciences is actively contributing to advancements in Biotechnology. Their latest funding round, Seed Round - Tiamat Sciences, raised $2.0M. Discover more about their projects, partnerships, and impact on our platform.